
Osteoporosis and Diabetes: Pros and Cons to Antidiabetic Regimens
Home / Specialties / Bone & Joint / Osteoporosis and Diabetes: Pros and Cons to Antidiabetic Regimens
Osteoporosis and Diabetes: Pros and Cons to Antidiabetic Regimens
Study aims to distinguish different antidiabetic drugs and their effect on osteoporosis in people with diabetes.
Osteoporosis and type 2 diabetes have recently been the focus of study in recent years. Osteoporosis is a bone condition defined by low bone mass, increased fragility, decreased bone quality, and an increased fracture risk. Research has shown that people with tyope 2 diabetes are at risk for developing osteoporosis and fractures. The incidence of fractures increases with age and therefore osteoporosis is most likely seen in individuals 50 years or older. The increase in fractures poses an increased mortality rate among patients with osteoporosis. This mortality rate is increased when people with type 2 diabetes develop osteoporosis.
There are many risk factors of osteoporosis and bone fractures. According to the World Health Organization, individuals with low bone mass and increased fragility are most susceptible to fractures and osteoporosis. The Nord-Trondelag Health Survey from Norway showed a dramatic increase in hip fractures among type 1 females. As such, the longer an individual is diagnosed with diabetes, the lower his or her bone mineral density (BMD) becomes. In addition, it has been reported that women with type 1 diabetes are more prone to developing fractures and ultimately osteoporosis when compared to females without diabetes. It is suggested that insulin plays a role in diabet
Continue
reading